Instrument overview
AVXLAnavex Life Sciences Corp.
StockNasdaqUnited StatesHealth careEU retail investors: available
+6.1% today · −83.3% over a year
No score: too little data.
Trend, Stability: among the weakest. No dividend.
Anavex Life Sciences Corp. (AVXL) belongs to the Health care sector and is listed on Nasdaq; country: United States. Its market value is about €101M. Over the past 12 months the price changed by −83.3%, with an annualised volatility of 97% and a largest fall of 84%.
Smart Score
How it is scored →Not scored: not enough data for a fair comparison.
Factor scores
Price trend over the last 12 and 6 months (excluding the last month) and distance from the 52-week high. More in the glossary →better than 0% of peers
Lower price swings, lower market sensitivity (beta) and shallower drawdowns score higher. More in the glossary →better than 2% of peers
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- 12-month trend (ex last month)weighs on the score · better than 1% of peers
- Volatility (1 y)weighs on the score · better than 8% of peers
- Max drawdown (3 y)weighs on the score · better than 4% of peers
Red flags and notes
- Caution. Share count growing 3–10 % a year over three years. More in the glossary → Share count growing 3–10 % a year over three years.
- Caution. Accruals or the Beneish M-score are in the watch zone. More in the glossary → Accruals or the Beneish M-score are in the watch zone.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Valuation
- P/B
- 1.0
- Market cap (EUR)
- €101M
Profitability and debt
- Return on equity
- −12.8%
Dividends
- Dividend yield
- 0.00%
- Years without a lower dividend
- 0
Returns and risk
- 1 day
- +6.1%
- 1 month
- −18.1%
- 1 year
- −83.3%
- Volatility, 1 yr
- 97.1%
- Max drawdown, 1 yr
- −83.9%
- Beta
- 1.50
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
Similar companies
Same sector and region, closest in market value.
| HCATHealth Catalyst | 1/10 | 0.0% | −46.6% |
|---|---|---|---|
| SKINSkinHealth Systems | 2/10 | 0.0% | −40.1% |
| BDTXBlack Diamond Therapeutics Inc | —/10 | 0.0% | −52.2% |
| CHRSCoherus Oncology | —/10 | 0.0% | −39.0% |
| LENZLENZ Therapeutics, Inc. | 1/10 | 0.0% | −81.3% |
| FRNMFreenome Inc. | —/10 | 0.0% | −1.2% |
| VXRTVaxart Inc | —/10 | 0.0% | −9.8% |
| ATRAAtara Biotherapeutics Inc | —/10 | 0.0% | −30.7% |
News and filings
- ANAVEX LIFE SCIENCES CORP.: 8-K — Director or officer change
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 3 Nov 2026
- ANAVEX LIFE SCIENCES CORP.: 8-K — Director or officer change; other events
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 2 Nov 2026
- ANAVEX LIFE SCIENCES CORP.: 8-K — Other events
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 20 Oct 2026
- ANAVEX LIFE SCIENCES CORP.: 8-K — Other events
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 15 Oct 2026
- ANAVEX LIFE SCIENCES CORP.: 8-K — Change in control; shareholder vote results
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 29 Sep 2026
- ANAVEX LIFE SCIENCES CORP.: 8-K — Other events
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 10 Sep 2026
- ANAVEX LIFE SCIENCES CORP.: 8-K — Other events
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 3 Sep 2026
- ANAVEX LIFE SCIENCES CORP.: 10-Q — Quarterly report for the period ending 30 Jun 2026
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 29 Aug 2026
- ANAVEX LIFE SCIENCES CORP.: 10-Q — Quarterly report for the period ending 31 Mar 2026
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 29 Aug 2026
- ANAVEX LIFE SCIENCES CORP.: 10-Q/A (amendment) — Quarterly report for the period ending 31 Dec 2025
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 29 Aug 2026
- ANAVEX LIFE SCIENCES CORP.: 10-K/A (amendment) — Annual report for the period ending 30 Sep 2025
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 29 Aug 2026
- ANAVEX LIFE SCIENCES CORP.: 8-K — Results of operations
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 25 Aug 2026
- ANAVEX LIFE SCIENCES CORP.: 8-K — Regulation FD disclosure
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 17 Aug 2026
What the marks mean
- FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
- Media reportA headline from a named media outlet. We link to it and do not check it.
- RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.
Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
Show the log: 1 entry
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| First rating | —/10 | — · — | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.